Addyi (flibanserin) Update

Addyi will be available in pharmacies on October 17th. The medical staff at Maze is all set to prescribe Addyi. We have passed the required exams and are certified prescribers. We are looking forward to offering this medication when we feel it is appropriate. It does seem this medication works best for women who had …

Continue Reading

Addyi (Flibanserin) approved by the FDA.

Addyi, also known as Flibanserin, was recently approved by the FDA to treat low sexual desire in women. It is the first FDA approved medication for female sexual dysfunction. Addyi is a non-hormonal oral medication, with a seemingly low side effect profile, that in essence increases dopamine and noradrenaline while reducing serotonin in the brain …

Continue Reading

Flibanserin.

Dr. Steven Snyder is a sex therapist as well as a medical doctor and wrote this excellent article about Flibanserin in Psychology Today, the so-called “pink viagra” for women. Professionals working in the field of female sexual health are anxiously awaiting the FDA’s decision on whether or not they will approve Flibanserin. Dr. Snyder ascertains …

Continue Reading

What is Flibanserin?

I think this is a great article that talks about the medication Flibanserin and the controversy surrounding FDA approval for medications to treat female sexual dysfunction. Flibanserin is a non-hormonal oral medication, with a seemingly low side effect profile, that in essence increases dopamine and noradrenalin while reducing serotonin in the brain. According to some …

Continue Reading

Have the sex life you desire.

Daniel Bergner, is a contributor for the New York Times Magazine and author of several books including, The Other Side of Desire, which I loved. He just wrote a new book which was released last week, What do Women Want? Adventures in the Science of Female Desire. An excerpt from the book just appeared in …

Continue Reading

A pill for low libido?

There was a recent article in The New York Times Magazine that has generated some buzz in the field of human sexuality. The article was written by Daniel Bergner, a contributing writer for the NY Times magazine and is an adaptation from his new book, What Do Women Want?: Adventures in the Science of Female …

Continue Reading

Our sexual culture and The New York Times.

The latest public figure to make journalistic hay from the flibanserin controversy is Camille Paglia, whose editorial in The New York Times, ”No Sex Please, We’re Middle Class, “ seems to be getting some play on my twitter feed. It’s a fun read, but she throws a lot of things together that I’m not sure …

Continue Reading